Aerovironment Shares Tumble 2.27 with 52.82 Volume Drop to 404th Rank as Earnings Misses and Contract Risks Weigh

Generated by AI AgentAinvest Volume RadarReviewed byAInvest News Editorial Team
Friday, Mar 13, 2026 8:39 pm ET2min read
AVAV--
Aime RobotAime Summary

- AerovironmentAVAV-- (AVAV) fell 2.27% on March 13, 2026, with trading volume dropping 52.82% to $0.29B, ranking 404th in liquidity.

- Q3 2026 earnings missed estimates by 50% (EPS $0.44 vs. $0.80), while SCAR contract uncertainty triggered a 17.42% selloff on March 2.

- Legal investigations and revised FY2026 guidance (EPS $2.75–$3.10) highlight $1.7B revenue risk from potential SCAR contract loss.

- Analysts remain divided: some see long-term AI/drone growth potential, while others warn of governance risks and earnings volatility.

Market Snapshot

Aerovironment (AVAV) closed on March 13, 2026, with a 2.27% decline in share price, marking a continuation of its recent downward trend. Trading volume for the day totaled $0.29 billion, a sharp 52.82% decrease from the previous day’s activity, reflecting subdued investor interest. The stock ranked 404th in trading activity among all listed equities, underscoring its reduced liquidity amid ongoing market uncertainty. This performance follows a series of negative catalysts, including earnings misses, contract risks, and legal investigations, which have pressured investor sentiment in recent months.

Key Drivers Behind the Decline

Aerovironment’s recent stock price weakness is driven by a confluence of operational, legal, and strategic headwinds. The most immediate factor was its Q3 fiscal 2026 earnings report on December 9, 2025, which revealed a significant shortfall in both revenue and profitability. The company reported earnings per share (EPS) of $0.44, far below the $0.80 consensus estimate, and posted a net loss of $67.4 million—a stark contrast to a $21.2 million profit in the prior-year period. Gross margins plummeted to 20.9% from 43%, as cost of goods sold surged to 79% of revenue. This poor performance triggered a 12.85% drop in share price on December 10, erasing over $36 in value per share.

Compounding these issues, Aerovironment’s largest contract—the $1.4 billion U.S. Space Force Satellite Communications Augmentation Resource (SCAR) program—has become a focal point of uncertainty. On March 2, 2026, Raymond James downgraded its rating on AVAVAVAV-- from “Strong Buy” to “Underperform,” citing the potential termination or reallocation of the SCAR contract. The program, which accounts for a critical portion of the company’s near-term revenue, is now under review by the Space Force, with work possibly split among new vendors or paused entirely. This development prompted another sharp selloff, with shares falling 17.42% to $208.32 on March 2. Analysts have since adjusted their price targets downward, with Robert W. Baird cutting its target to $235 from $260 and Royal Bank of Canada reducing its estimate to $250 from $325.

Legal scrutiny has further amplified volatility. Pomerantz LLP, a prominent securities law firm, launched an investigation into AerovironmentAVAV-- on March 12, 2026, alleging potential securities fraud or unlawful business practices. The firm’s involvement—a direct consequence of the earnings miss and SCAR-related risks—has heightened investor caution. The investigation, while not yet alleging wrongdoing, has introduced a layer of uncertainty that could lead to additional volatility or regulatory action. This legal overhang, combined with the company’s deteriorating financial metrics, has pressured broader market confidence.

Despite these challenges, some analysts maintain a cautiously optimistic view of Aerovironment’s long-term prospects. The company has expanded its counter-UAS and AI sensing capabilities, positioning itself to benefit from rising military demand for drone-related technologies. However, near-term risks remain pronounced. Management’s FY2026 guidance, which cut adjusted EPS expectations to $2.75–$3.10 from $3.40–$3.55, has underscored the fragility of its business model. Additionally, the potential loss of the SCAR contract represents a $1.7 billion revenue risk, which could delay or eliminate key growth opportunities.

The stock’s trajectory will likely hinge on the resolution of these interconnected issues. A favorable outcome in the SCAR program review, coupled with stronger-than-expected earnings in subsequent quarters, could stabilize sentiment. Conversely, further delays or legal complications may exacerbate the downward trend. For now, investors remain cautious, with the MarketBeat consensus target at $341.39—still a 6.06% premium to the March 13 closing price—reflecting a divided view between those who see value in Aerovironment’s core competencies and those who view the current risks as insurmountable.

Hunt down the stocks with explosive trading volume.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet